OCD does not respond to medication the same way depression or anxiety does. There are specific, well-established differences that change how treatment should be approached:¹˒²˒³˒⁴

Higher doses are required. OCD typically requires SSRI doses at the upper end — or beyond — the ranges used for other conditions. A dose that effectively treats depression may be subtherapeutic for OCD. When a general prescriber uses standard dosing, the medication may appear ineffective when it was simply never given at an adequate dose.¹˒²˒³˒⁴

Longer treatment trials are necessary. Unlike depression, where response may be seen within a few weeks, OCD often requires 12 weeks at anti-obsessional doses before effectiveness can be fully assessed. Some patients who appear to have a poor response at 12 weeks continue to improve with additional time.²˒³˒⁴

Response looks different. Full remission with medication alone occurs in approximately 11% of patients. Most people experience a 20–40% reduction in symptom severity — meaningful improvement, but not the complete resolution that many expect.

Understanding what a realistic medication response looks like is part of specialized care.²

Augmentation is often needed.

Up to 40–60% of patients have residual symptoms after initial SSRI treatment. Evidence-based augmentation strategies — including clomipramine augmentation, glutamatergic medications, and select antipsychotic augmentation — can produce additional improvement when first-line treatment is not sufficient.²˒³˒⁴
Maintenance treatment is the standard. OCD is a chronic condition. Relapse rates reach up to 80% when medication is discontinued after short treatment periods, compared to 25–40% after two or more years of treatment. For most patients, ongoing medication management is recommended.²˒⁵

SSRI/SRI Medications and Anti-Obsessional Dosing for OCD¹˒⁴

• Fluoxetine (Prozac) — 80–120 mg/day
• Fluvoxamine (Luvox) — 400–450 mg/day
• Sertraline (Zoloft) — 400 mg/day
• Paroxetine (Paxil) — 80–100 mg/day
• Escitalopram (Lexapro) — 40–60 mg/day
• Clomipramine (Anafranil) — 250 mg/day

These doses are significantly higher than what is typically prescribed for depression or generalized anxiety. This is one of the most common reasons OCD is undertreated — the medication may be correct, but the dose is not.¹˒²˒³˒⁴

Augmentation Strategies

When SRI treatment alone is insufficient, the following augmentation approaches have evidence of benefit:
Clomipramine added to an SSRI — low-dose clomipramine augmentation of an SSRI can be effective, particularly in patients who cannot tolerate high-dose SSRI therapy. The combination of clomipramine with fluvoxamine can be particularly effective due to favorable pharmacokinetic interactions, though TCA levels must be monitored.¹˒⁴

Glutamatergic medications — memantine (Namenda) or riluzole have a favorable side effect profile and growing evidence supporting their use as augmentation agents.¹˒³˒⁴

Antipsychotic augmentation — aripiprazole (Abilify) or risperidone (Risperdal) are the most evidence-based options, with benefit in approximately one-third of treatment-resistant patients. Comorbid tic disorders predict a particularly favorable response.¹˒³˒⁴